New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
08:13 EDTMRMindray Medical sees FY12 revenue $1.06B, consensus $1.06B
Based on the estimated full-year revenue, the company anticipates 2012 non-GAAP net income to be approximately $207M, growing approximately 16% year-over-year. The non-GAAP net income figure excludes the tax benefits related to the key software enterprise status and assumes a corporate income tax rate of 15% applicable to the Shenzhen subsidiary.
News For MR From The Last 14 Days
Check below for free stories on MR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 11, 2014
13:14 EDTMRMindray Medical downgraded earlier to Equal Weight at Morgan Stanley
Morgan Stanley downgraded Mindray Medical earlier due to continued operating deleveraging. Target to $37 from $44.
April 7, 2014
10:18 EDTMRFollow-up: Mindray Medical downgraded at Goldman
Subscribe for More Information
10:15 EDTMRMindray Medical downgraded to Neutral from Buy at Goldman
Price target lowered to $31.20 from $45.50.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use